Morgan D. Fullerton
Institute of Infection and Immunity(CA)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Liver Disease Diagnosis and Treatment, Adipokines, Inflammation, and Metabolic Diseases, Peroxisome Proliferator-Activated Receptors
Most-Cited Works
- → Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin(2013)857 cited
- → The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase(2012)728 cited
- → Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis(2014)479 cited
- → MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis(2015)384 cited
- → Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity(2011)329 cited
- → NOD1 Activators Link Innate Immunity to Insulin Resistance(2011)244 cited
- → Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4(2017)238 cited
- → Defective NOD 2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance(2015)188 cited
- → Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity(2015)153 cited
- → Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity(2012)144 cited